Testing a New Method to Improve Informed Consent in Prison Research
Spark BATIR
1 other identifier
interventional
100
1 country
2
Brief Summary
Understanding of informed consent is often limited in prison, due to unique challenges faced by detained people. This study will test a modified "teach-to-goal" informed consent process compared to standard procedures. Conducted within a larger study on psychiatric outcomes, it aims to enhance ethical practices for vulnerable populations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2024
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 18, 2024
CompletedFirst Posted
Study publicly available on registry
April 22, 2024
CompletedStudy Start
First participant enrolled
May 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 30, 2026
March 17, 2026
March 1, 2026
2.4 years
April 18, 2024
March 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Understanding of the informed consent (binary)
20 questions (true/false) evaluating whether the participant understood the information. A binary variable coded 1 if all questions are answered correctly and 0 otherwise will be computed.
Immediately after the intervention
Secondary Outcomes (2)
Understanding of the informed consent (continuous)
Immediately after the intervention
Evaluation of the informed consent
Immediately after the intervention
Study Arms (2)
Standard informed consent
NO INTERVENTIONAccording to ethical requirements of Swiss Human Research Act, the interviewer will explain the nature of the study, its purposes, duration, the potential risks and benefits it entails, and study procedures. He will inform that study participation is voluntary and that participants may withdraw at any time. He will also explain that the study is independent from the prison authorities. Participants will then be given time to read the informed consent, or, if they are not able to read, it will be read to them by the interviewer. The interviewer will answer all questions.
Modified teach-to-goal informed consent
EXPERIMENTALThe standard process will first be used. After that, the interviewer will ask participants to summarize the content of the informed consent. The interviewer will correct not-well understood components and ask questions about forgotten components. In case of misconceptions, the participant will be asked to summarize again the corresponding components. A list of key components to be addressed will be developed by study team members, including experts in prison research and ethics, based on components listed in Art. 16 of the Swiss Human Research Act. The material of the informed consent of the parent-randomized controlled trial will be used.
Interventions
Enhanced procedure to improve informed consent in vulnerable populations.
Eligibility Criteria
You may qualify if:
- age ≥ 18 years
- good command of French
- absence of acute psychiatric disorder
- providing written informed consent for study participation in the parent-RCT
You may not qualify if:
- \- none.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Stéphanie Baggiolead
- University of Berncollaborator
- Leiden Universitycollaborator
- School of Health Sciences Fribourgcollaborator
- University Hospital, Genevacollaborator
- University of Lausannecollaborator
Study Sites (2)
Geneva University Hospitals
Geneva, Canton of Geneva, 1211, Switzerland
Geneva University Hospitals
Geneva, Canton of Geneva, 1226, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Prof. Dr. phil.
Study Record Dates
First Submitted
April 18, 2024
First Posted
April 22, 2024
Study Start
May 1, 2024
Primary Completion (Estimated)
September 30, 2026
Study Completion (Estimated)
September 30, 2026
Last Updated
March 17, 2026
Record last verified: 2026-03